Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review

Remarkable Response of Metastatic Gallbladder Carcinoma to Apatinib After Failed Multiline Chemotherapies: A Case Report and Literature Review

Gallbladder carcinoma (GBC) is a relatively rare and aggressive malignant tumor with a poor prognosis. A systematic review of current clinical studies illustrates an extreme paucity of second-line therapeutic options following the failure of standard-of-care cisplatin-gemcitabine chemotherapy. The e...

Full description

Bibliographic Details
Main Authors: Mengxi Zhang, Pengfei Zhang, Kexun Zhou, Qiu Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Oncology
Subjects:
metastatic gallbladder cancer
anti-angiogenesis
apatinib
chemotherapy
targeted therapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01180/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01180/full

Similar Items